Atrial Fibrillation Programs

Blueprint for Disease-Centered Investments

This is a preview of restricted content.

Full access to this content is reserved for Cardiovascular Roundtable members. Log in now or learn more about Cardiovascular Roundtable.

About the Webconference

The prevalence of atrial fibrillation (a-fib) is expected to grow to nearly 16 million by 2050, with a price tag of $26 billion per year. With no cure-all treatment option, a-fib patients often seek care from multiple specialists and require long-term management.

A sizeable market and significant improvements in catheter ablation technology in recent years have made a-fib a prime opportunity for many CV programs. However, the decision to pursue the a-fib opportunity requires a concerted approach to generate referrals, coordinate longitudinal care, and foster multidisciplinary practice.

This presentation provides structural and operational guidance on optimizing atrial fibrillation centers, including profiles from progressive programs.

Presenter: Carly Anderson

View the On-Demand Presentation

Watch the video Stream video recording

Download PDF Download PDF

Topics: Cardiovascular, Service Lines, Electrophysiology, Strategy, Market Trends